Home > Financial Ratios > PANACEA BIOTEC

PANACEA BIOTEC
Core EBITDA Margin

    Back to All Ratios
PANACEA BIOTEC is part of below Screeners ↓
Best Quarterly Growth Small Cap Stocks
AD     Remove this Ad

PANACEA BIOTEC Last 5 Year Core EBITDA Margin History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
   Core EBITDA Margin(%) -4.61-3.53-20.68-1.9011.70

What is the latest Core EBITDA Margin ratio of PANACEA BIOTEC ?

The latest Core EBITDA Margin ratio of PANACEA BIOTEC is -4.61 based on Mar2025 Consolidated results.
Year Core EBITDA Margin
Mar2025-4.61
Mar2024-3.53
Mar2023-20.68
Mar2022-1.90
Mar202111.70

How is Core EBITDA Margin of PANACEA BIOTEC Trending?

Years Core EBITDA Margin % Change
Mar2025 -4.61
Negative
Mar2024 -3.53
Negative
Mar2023 -20.68
Negative
Mar2022 -1.9
Negative
Mar2021 11.7 -

Other Financial Ratios of PANACEA BIOTEC


Compare Core EBITDA Margin ratio of peers of PANACEA BIOTEC

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
PANACEA BIOTEC ₹2,162.1 Cr 9.5% 3.6% -21.8% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹406,243.0 Cr -1.4% -7.2% 0.5% Stock Analytics
DIVIS LABORATORIES ₹167,179.0 Cr 5.7% 0.3% 14.6% Stock Analytics
TORRENT PHARMACEUTICALS ₹140,670.0 Cr 1.5% -6.5% 28.1% Stock Analytics
DR REDDYS LABORATORIES ₹101,932.0 Cr 0.7% -7.4% 9.9% Stock Analytics
CIPLA ₹99,417.9 Cr 0.5% -7.1% -14.4% Stock Analytics


PANACEA BIOTEC Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
PANACEA BIOTEC

9.5%

3.6%

-21.8%

SENSEX

0.6%

1.5%

6.6%


You may also like the below Video Courses